Clinical Trials · NCT03696121
Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Nottingham
- Enrollment
- 54
- Start date
- Apr 2019
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Number of eligible patients who received allocated treatment